ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal end-to-end drug development technology platform, LifeSphere®, integrates ArisGlobal proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures compliance and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Ennov Group is an Independent Software Vendor with Electronic Document Management (EDMS) & Business Process Management (BPM) for Life Science Industries. Ennov Solutions, Inc. is a software publisher specializing in Quality Management Systems, Regulatory Compliance Solutions and Clinical Trial Management Software with more than 450 clients worldwide and 15 years experience in Pharmaceutical, Cosmetic and Healthcare Industries.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 79,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.